Genetic abberations in gallbladder cancer

Surgical Oncology

Volumn 21, Issue 1, 2012, Pages 37-43

  Maurya, Sanjeev K ^a   Tewari, Mallika ^a   Mishra, Raghvendra R ^a   Shukla, Hari S ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Gallbladder carcinoma; Genetic abnormality; Oncogenes; Tumor suppressor genes

Indexed keywords

ANGIOGENIC FACTOR; BEVACIZUMAB; BORTEZOMIB; CELL ADHESION MOLECULE; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERLOTINIB; HORMONE RECEPTOR; K RAS PROTEIN; MESSENGER RNA; SORAFENIB; ANGIOGENIC PROTEIN; CASPASE; CELL CYCLE PROTEIN; CELL SURFACE RECEPTOR; COMPLEMENT COMPONENT C3B RECEPTOR; CR1 PROTEIN, HUMAN; MUCIN; TELOMERASE;

APOPTOSIS; BILE DUCT CARCINOMA; BREAST CANCER; CANCER GENETICS; CARCINOGENESIS; CARCINOMA IN SITU; CELL CYCLE REGULATION; CHOLECYSTITIS; CHOLELITHIASIS; DOWN REGULATION; DYSPLASIA; FRAMESHIFT MUTATION; GALLBLADDER CARCINOMA; GENE EXPRESSION PROFILING; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; METAPLASIA; MICROSATELLITE INSTABILITY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; REVIEW; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; GALLBLADDER TUMOR; GENETICS; METABOLISM; ONCOGENE;

ANGIOGENIC PROTEINS; APOPTOSIS; CASPASES; CELL ADHESION MOLECULES; CELL CYCLE PROTEINS; GALLBLADDER NEOPLASMS; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE INSTABILITY; MUCINS; ONCOGENES; RECEPTORS, CELL SURFACE; RECEPTORS, COMPLEMENT 3B; TELOMERASE;

EID: 84855846648     PISSN: 09607404     EISSN: 18793320     Source Type: Journal    
DOI: 10.1016/j.suronc.2010.09.003     Document Type: Review

References (81)

1. G. Sanders, and A.N. Kingsnorth Gallstones BMJ 335 7614 2007 Aug 11 295 299 (Pubitemid 47280806)
2. M. Kayahara, and T. Nagakawa Recent trends of gallbladder cancer in Japan: an analysis of 4,770 patients Cancer 110 3 2007 Aug 1 572 580 (Pubitemid 47106146)
3. H.S. Shukla Gallbladder cancer J Surg Oncol 93 8 2006 Jun 15 604 606 (Pubitemid 43855687)
4. A.W. Hsing, Y.T. Gao, T.Q. Han, A. Rashid, L.C. Sakoda, and B.S. Wang Gallstones and the risk of biliary tract cancer: a population-based study in China Br J Cancer 97 11 2007 Dec 3 1577 1582 (Pubitemid 350175843)
5. S. Ishiguro, M. Inoue, N. Kurahashi, M. Iwasaki, S. Sasazuki, and S. Tsugane Risk factors of biliary tract cancer in a large-scale population-based cohort study in Japan (JPHC study); with special focus on cholelithiasis, body mass index, and their effect modification Cancer Causes Control 19 1 2008 Feb 33 41
6. G. Miller, N.D. Socci, D. Dhall, M. D'Angelica, R.P. DeMatteo, and P.J. Allen Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract J Exp Clin Cancer Res 28 2009 62
7. J.C. Roa, Q. Vo, J.C. Araya, M. Villaseca, P. Guzman, and G.S. Ibacache Inactivation of CDKN2A gene (p16) in GBC Rev Med Chil 132 11 2004 Nov 1369 1376 (Pubitemid 40543074)
8. S.N. Pandey, M. Dixit, G. Choudhuri, and B. Mittal Lipoprotein receptor associated protein (LRPAP1) insertion/deletion polymorphism: association with gallbladder cancer susceptibility Int J Gastrointest Cancer 37 4 2006 124 128 (Pubitemid 351642214)
9. H.J. Choi, S.S. Yun, H.J. Kim, and J.H. Choi Expression of p16 protein in gallbladder carcinoma and its precancerous conditions Hepatogastroenterology 57 97 2010 Jan-Feb 18 21
10. T. Takahashi, N. Shivapurkar, E. Riquelme, H. Shigematsu, J. Reddy, and M. Suzuki Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis Clin Cancer Res 10 18 Pt 1 2004 Sep 15 6126 6133 (Pubitemid 39287518)
11. T.J. Rizvi, and S.J. Zuberi Risk factors of gallbladder cancer in Karachi J Ayub Med Coll Abborttabad 15 2003 16 18
12. H.S. Shukla, K. Awasthi, Y.P. Naithani, and S.C. Gupta A clinico-pathological study of carcinoma of the gall bladder Indian J Cancer 18 3 1981 Sep 198 201 (Pubitemid 12061186)
13. Y.N. Silk, H.O. Douglass, H.R. Nava, and D.L. Driscoll Carcinoma of the gallbladder Ann Surg 210 1989 751 757
14. S. Sheth, A. Bedford, and S. Chopra Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy Am J Gastroenterol 95 2000 1402 1410 (Pubitemid 30396295)
15. P. Chaurasia, M.K. Thakur, and H.S. Shukla What causes cancer gallbladder?: a review HPB Surg 11 4 1999 217 224 (Pubitemid 29405899)
16. I. Roa, X.D. Aretxabala, J.C. Araya, and J. Roa Preneoplastic lesions in gallbladder cancer J Surg Oncol 93 2006 615 623 (Pubitemid 43855690)
17. Y.H. Xuan, Y.L. Choi, Y.K. Shin, M.C. Kook, S.W. Chae, and S.M. Park An immunohistochemical study of the expression of cell-cycle-regulated proteins p53, cyclin D1, RB, p27, Ki67 and MSH2 in GBC and its precursor lesions Histol Histopathol 20 1 2005 Jan 59 66 (Pubitemid 40028983)
18. M. Nagahashi, Y. Ajioka, I. Lang, Z. Szentirmay, M. Kasler, and H. Nakadaira Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary World J Gastroenterol 14 1 2008 Jan 7 70 75 (Pubitemid 351314329)
19. P. Billo, C. Marchegiani, C. Capella, and F. Sessa Expression of p53 in GBC and in dysplastic and metaplastic lesions of the surrounding mucosa Pathologica 92 4 2000 Aug 249 256
20. K. Hanada, A. Tsuchida, and G. Kajiyama Cellular kinetics and gene mutations in gallbladder mucosa with an anomalous junction of pancreaticobiliary duct J Hepatobiliary Pancreat Surg 6 3 1999 223 228
21. K. Fujii, H. Yokozaki, W. Yasui, H. Kuniyasu, M. Hirata, and G. Kajiyama High frequency of p53 gene mutation in adenocarcinomas of the gallbladder Cancer Epidemiol Biomarkers Prev 5 6 1996 Jun 461 466 (Pubitemid 26182661)
22. I.I. Wistuba, R. Ashfaq, A. Maitra, H. Alvarez, E. Riquelme, and A.F. Gazdar Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma Am J Pathol 160 6 2002 Jun 2073 2079 (Pubitemid 34663400)
23. T. Yoshida, T. Sugai, W. Habano, S. Nakamura, N. Uesugi, and O. Funato Microsatellite instability in gallbladder carcinoma: two independent genetic pathways of gallbladder carcinogenesis J Gastroenterol 35 10 2000 768 774
24. T.P. Priya, V.K. Kapoor, N. Krishnani, V. Agrawal, and S. Agarwal Fragile histidine triad (FHIT) gene and its association with p53 protein expression in the progression of gall bladder cancer Cancer Invest 27 7 2009 Aug 764 773
25. J.C. Roa, I. Roa, X. de Aretxabala, A. Melo, G. Faria, and O. Tapia K-ras gene mutation in GBC Rev Med Chil 132 8 2004 Aug 955 960
26. M. Koda, K. Yashima, K. Kawaguchi, H. Andachi, A. Hosoda, and G. Shiota Expression of Fhit, Mlh1, and P53 protein in human gallbladder carcinoma Cancer Lett 199 2 2003 Sep 25 131 138 (Pubitemid 37297706)
27. H.B. Ma, H.T. Hu, Z.L. Di, Z.R. Wang, J.S. Shi, and X.J. Wang Association of cyclin D1, p16 and retinoblastoma protein expressions with prognosis and metastasis of gallbladder carcinoma World J Gastroenterol 11 5 2005 Feb 7 744 747
28. I.I. Wistuba, J.F. Miquel, A.F. Gazdar, and J.A. Saavedra Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas Hum Pathol 30 1 1999 Jan 21 25 (Pubitemid 29037389)
29. H. Tadokoro, T. Shigihara, T. Ikeda, M. Takase, and M. Suyama Two distinct pathways of p16 gene inactivation in gallbladder cancer World J Gastroenterol 13 47 2007 Dec 21 6396 6403
30. M.K. Singh, K. Chetri, U.B. Pandey, V.K. Kapoor, B. Mittal, and G. Choudhuri Mutational spectrum of K-ras oncogene among Indian patients with gallbladder cancer J Gastroenterol Hepatol 19 8 2004 Aug 916 921 (Pubitemid 39093210)
31. J.C. Roa, R.L. Anabalon, E.O. Tapia, A.A. Melo, U.X. de Aretxabala, and E.I. Roa Frequency of K-ras mutation in biliary and pancreatic tumors Rev Med Chil 133 12 2005 Dec 1434 1440
32. A.A. Saetta K-ras, p53 mutations, and microsatellite instability (MSI) in gallbladder cancer J Surg Oncol 93 2006 644 649 (Pubitemid 43855695)
33. K. Nakazawa, Y. Dobashi, S. Suzuki, H. Fujii, Y. Takeda, and A. Ooi Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers J Pathol 206 3 2005 Jul 356 365 (Pubitemid 40903200)
34. A. Chaube, M. Tewari, R.S. Garbyal, U. Singh, and H.S. Shukla Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer in Indian patients BMC Cancer 6 2006 May 10 126
35. V. Boudny, and S. Nakano Src tyrosine kinase but not activated Ras augments sensitivity to taxanes through apoptosis in human adenocarcinoma cells Anticancer Res 23 1A 2003 Jan-Feb 7 12 (Pubitemid 36358493)
36. B. Qin, H. Ariyama, E. Baba, R. Tanaka, H. Kusaba, and M. Harada Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells Cancer Chemother Pharmacol 58 5 2006 Nov 577 584 (Pubitemid 44167382)
37. N. Shafizadeh, J.P. Grenert, V. Sahai, and S. Kakar Epidermal growth factor receptor and HER-2/neu status by immunohistochemistry and fluorescence in situ hybridization in adenocarcinomas of the biliary tree and gallbladder Hum Pathol 41 4 2010 Apr 485 492
38. J. Harder, O. Waiz, F. Otto, M. Geissler, M. Olschewski, and B. Weinhold EGFR and HER2 expression in advanced biliary tract cancer World J Gastroenterol 15 36 2009 Sep 28 4511 4517
39. W.C. Su, S.C. Shiesh, H.S. Liu, C.Y. Chen, N.H. Chow, and X.Z. Lin Expression of oncogene products HER2/Neu and Ras and fibrosis-related growth factors bFGF, TGF-beta, and PDGF in bile from biliary malignancies and inflammatory disorders Dig Dis Sci 46 7 2001 Jul 1387 1392
40. T. Kawamoto, S. Krishnamurthy, E. Tarco, S. Trivedi, I.I. Wistuba, and D. Li HER receptor family: novel candidate for targeted therapy for gallbladder and extrahepatic bile duct cancer Gastrointest Cancer Res 1 6 2007 Nov 221 227
41. Y.M. Zhou, Y.M. Li, N. Cao, Y. Feng, and F. Zeng Significance of expression of epidermal growth factor (EGF) and its receptor (EGFR) in chronic cholecystitis and gallbladder carcinoma Ai Zheng 22 3 2003 Mar 262 265
42. F. Leone, G. Cavalloni, Y. Pignochino, I. Sarotto, R. Ferraris, and W. Piacibello Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma Clin Cancer Res 12 6 2006 Mar 15 1680 1685
43. A.F. Hezel, and A.X. Zhu Systemic therapy for biliary tract cancers Oncologist 13 4 2008 April 415 423 (Pubitemid 351679921)
44. P.A. Philip, M.R. Mahoney, C. Allmer, J. Thomas, H.C. Pitot, and G. Kim Phase II study of erlotinib in patients with advanced biliary cancer J Clin Oncol 24 19 2006 July 3069 3074 (Pubitemid 46638942)
45. T.J. Lynch, D.W. Bell, R. Sordella, S. Gurubhagavatula, R.A. Okimoto, and B.W. Brannigan Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N Engl J Med 350 21 2004 May 2129 2139 (Pubitemid 38637993)
46. L.N. Xu, S.Q. Zou, and J.M. Wang Action and mechanism of Fas and Fas ligand in immune escape of gallbladder carcinoma World J Gastroenterol 11 24 2005 Jun 28 3719 3723
47. N. Turunen, P. Paakko, and Y. Soini Apoptosis in gallbladder carcinomas and dysplasias, its relation to the expression of caspases 3, 6 and 8 and apoptosis regulating proteins bcl-2, mcl-1 and bax Histol Histopathol 15 1 2000 Jan 53 60 (Pubitemid 30044289)
48. E. Sasatomi, O. Tokunaga, and K. Miyazaki Spontaneous apoptosis in gallbladder carcinoma. Relationships with clinicopathologic factors, expression of E-cadherin, bcl-2 protooncogene, and p53 oncosuppressor gene Cancer 78 10 1996 Nov 15 2101 2110 (Pubitemid 26367602)
49. N. Eguchi, K. Fujii, A. Tsuchida, S. Yamamoto, T. Sasaki, and G. Kajiyama Cyclin E overexpression in human gallbladder carcinomas Oncol Rep 6 1 1999 Jan-Feb 93 96
50. G. Ren, G. Yu, L.W. Liu, and L. Ma Expressions of Ep-CAM and cyclin D1 and their clinical significance in gallbladder carcinoma Zhonghua Zhong Liu Za Zhi 31 11 2009 Nov 841 844
51. A.M. Hui, L. Xin, Y.Z. Shi, T. Takayama, G. Torzilli, and M. Makuuchi Cyclin D1 overexpression is a critical event in gallbladder carcinogenesis and independently predicts decreased survival for patients with gallbladder carcinoma Clin Cancer Res 6 2000 4272 4277
52. Y.M. Jin, H. Yim, and C. Shim Cyclin E expression in benign and malignant epithelial neoplasms of the gallbladder Yonsei Med J 38 5 1997 Oct 301 306 (Pubitemid 127510908)
53. T. Itoi, Y. Shinohara, K. Takeda, K. Nakamura, K. Takei, and J. Sanada Nuclear cyclin D1 overexpression is a critical event associated with cell proliferation and invasive growth in gallbladder carcinogenesis J Gastroenterol 35 2 2000 142 149 (Pubitemid 30129006)
54. M. Filipits, H. Puhalla, and F. Wrba Low p27Kip1 expression is an independent prognostic factor in gallbladder carcinoma Anticancer Res 23 1B 2003 Jan-Feb 675 679 (Pubitemid 36358471)
55. I. Roa, M. Villaseca, J. Araya, J. Roa, X. de Aretxabala, and G. Ibacache CD44 (HCAM) expression in subserous gallbladder carcinoma Rev Med Chil 129 7 2001 Jul 727 734
56. L.R. Ylagan, J. Scholes, and R. Demopoulos Cd44: a marker of squamous differentiation in adenosquamous neoplasms Arch Pathol Lab Med 124 2 2000 Feb 212 215 (Pubitemid 30090604)
57. H. Kashiwagi, H. Kijima, S. Dowaki, Y. Ohtani, K. Tobita, and H. Yamazaki MUC1 and MUC2 expression in human gallbladder carcinoma: a clinicopathological study and relationship with prognosis Oncol Rep 8 3 2001 May-Jun 485 489 (Pubitemid 33758441)
58. M. Ghosh, H. Kamma, T. Kawamoto, N. Koike, M. Miwa, and V.K. Kapoor MUC 1 core protein as a marker of gallbladder malignancy Eur J Surg Oncol 31 8 2005 Oct 891 896 (Pubitemid 41435259)
59. T. Kawamoto, J. Shoda, T. Asano, T. Ueda, M. Furukawa, and N. Koike Expression of cyclooxygenase-2 in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder Int J Cancer 98 3 2002 Mar 20 427 434 (Pubitemid 34188686)
60. T. Kawamoto, J. Shoda, N. Miyahara, H. Suzuki, M. Furukawa, and T. Todoroki Expression of MUC1 recognized by a monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of carcinoma of the gallbladder Clin Exp Metastasis 21 4 2004 353 362
61. H.J. Chang, S.W. Kim, B.L. Lee, E.K. Hong, and W.H. Kim Phenotypic alterations of mucins and cytokeratins during gallbladder carcinogenesis Pathol Int 54 8 2004 Aug 576 584
62. M. Sasaki, T. Yamato, Y. Nakanuma, S.B. Ho, and Y.S. Kim Expression of MUC2, MUC5AC and MUC6 apomucins in carcinoma, dysplasia and non-dysplastic epithelia of the gallbladder Pathol Int 49 1 1999 Jan 38 44 (Pubitemid 29421946)
63. S.K. Maurya, T. Mallika, M.K. Thakur, K. Mohan, and H.S. Shukla Stage dependent expression MUC1 glycoprotein in gallbladder carcinoma J Cancer Res Exp Oncol 1 1 2009 October 001 007
64. X.Y. Jiao, M.D. Lu, J.F. Huang, L.J. Liang, and J.S. Shi Genomic determination of CR1 CD35 density polymorphism on erythrocytes of patients with gallbladder carcinoma World J Gastroenterol 10 23 2004 Dec 1 3480 3484
65. L. Wicherek, T.J. Popiela, K. Galazka, M.D. Wicherek, M. Oplawski, and A. Basta Metallothionein and RCAS1 expression in comparison to immunological cells activity in endometriosis, endometrial adenocarcinoma and endometrium according to menstrual cycle changes Gynecol Oncol 99 3 2005 Dec 622 630 (Pubitemid 41686546)
66. M. Nakashima, K. Sonoda, and T. Watanabe Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1 Nat Med 5 8 1999 Aug 938 942 (Pubitemid 29372422)
67. T. Oshikiri, Y. Hida, M. Miyamoto, H. Hashida, K. Katoh, and M. Suzuoki RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer Br J Cancer 85 12 2001 Dec 14 1922 1927 (Pubitemid 34775330)
68. M. Enjoji, K. Yamaguchi, M. Nakamuta, M. Nakashima, K. Kotoh, and M. Tanaka Movement of a novel serum tumour marker, RCAS1, in patients with biliary diseases Dig Liver Dis 36 9 2004 Sep 622 627 (Pubitemid 41122184)
69. A. Chen, and D. Huminer The role of estrogen receptors in the development of gallstones and gallbladder cancer Med Hypotheses 36 3 1991 Nov 259 260
70. K. Sumi, S. Matsuyama, Y. Kitajima, and K. Miyazaki Loss of estrogen receptor beta expression at cancer front correlates with tumor progression and poor prognosis of gallbladder cancer Oncol Rep 12 5 2004 Nov 979 984
71. V. Bhaskaran Hormonal receptors in carcinoma of the gallbladder Trop Gastroenterol 21 2 2000 Apr-Jun 48 50
72. Y. Ohtani, H. Kijima, S. Dowaki, H. Kashiwagi, K. Tobita, and M. Tsukui Stromal expression of thrombospondin-1 is correlated with growth and metastasis of human gallbladder carcinoma Int J Oncol 15 3 1999 Sep 453 457
73. Y.H. Zhi, R.S. Liu, M.M. Song, Y. Tian, J. Long, and W. Tu Cyclooxygenase-2 promotes angiogenesis by increasing vascular endothelial growth factor and predicts prognosis in gallbladder carcinoma World J Gastroenterol 11 24 2005 Jun 28 3724 3728 (Pubitemid 41149271)
74. T. Itoi, A. Tsuchida, F. Itokawa, A. Sofuni, T. Kurihara, and T. Tsuchiya Histologic and genetic analysis of the gallbladder in patients with occult pancreatobiliary reflux Int J Mol Med 15 3 2005 Mar 425 430
75. A.F. Dernburg Here, there, and everywhere: kinetochore function on holocentric chromosomes J Cell Biol 153 6 2001 Jun 11 F33 F38 (Pubitemid 34289253)
76. B. Luzar, M. Poljak, A. Cor, U. Klopcic, and V.F. Marolt Expression of human telomerase catalytic protein in gallbladder carcinogenesis J Clin Pathol 58 8 2005 Aug 820 825 (Pubitemid 41113388)
77. M. Moreno, F. Pimentel, A.F. Gazdar, I.I. Wistuba, and J.F. Miquel TP53 abnormalities are frequent and early events in the sequential pathogenesis of gallbladder carcinoma Ann Hepatol 4 3 2005 Jul-Sep 192 199
78. T. Kuroki, Y. Tajima, K. Matsuo, and T. Kanematsu Genetic alterations in gallbladder carcinoma Surg Today 35 2 2005 101 105 (Pubitemid 40202692)
79. K. Matsuo, T. Kuroki, F. Kitaoka, Y. Tajima, and T. Kanematsu Loss of heterozygosity of chromosome 16q in gallbladder carcinoma J Surg Res 102 2 2002 Feb 133 136 (Pubitemid 34969458)
80. K. Nakayama, M. Konno, A. Kanzaki, T. Morikawa, H. Miyashita, and T. Fujioka Allelotype analysis of gallbladder carcinoma associated with anomalous junction of pancreaticobiliary duct Cancer Lett 166 2 2001 May 26 135 141 (Pubitemid 32322658)
81. M. Hopfner, D. Schuppan, and H. Scherubl Targeted medical therapy of biliary tract cancer: recent advances and future perspectives World J Gastroenterol 14 46 2008 Dec 14 7021 7032